Azurity Pharmaceuticals acquires Covis Pharma
03/14/25, 12:18 PM
Location
Industry
pharmaceutical
medical
biotechnology
health care
manufacturing
health care
Azurity Pharmaceuticals announces the successful completion of its acquisition of Covis Group S.à r.l., now a wholly-owned subsidiary. This strategic acquisition enhances Azurity's leadership in branded pharmaceuticals and aims to better serve overlooked patients globally. The collaboration is expected to leverage the strengths of both organizations to accelerate drug development.
Company Info
Location
Woburn, Massachusetts, United States
Company info
Azurity is a privately-held pharmaceutical company specializing in providing innovative, high-quality medicines that serve overlooked patients. Azurity supplies a large number of products to treat a wide range of medical conditions. These include cardiovascular, central nervous system, endocrine, gastro-intestinal, anti-infective and oncology medicines. Many of Azurity's medicines are dose-form innovations for patients with needs that are not met by other available products. Azurity's medicines have benefited millions of people.